Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 895

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 895
---
 or in the aggregate, has had a Material Adverse Effect; and
none of the Company or any of its Subsidiaries has taken any action that, if taken after the date of this Agreement, would constitute a breach of any of the covenants set forth in .

Section 3.8 . Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect, (a) there is no suit, claim, action, proceeding, arbitration, mediation or investigation (each, an “”) pending or, to the knowledge of the Company, threatened against the Company or any of its Subsidiaries or any
of their respective properties or assets by or before any Governmental Entity and (b) neither the Company nor any of its Subsidiaries nor any of their respective properties is or are subject to any outstanding judgment, order, injunction, rule
or decree of any Governmental Entity. As of the date of this Agreement, there is no Action pending or, to the knowledge of the Company, threatened seeking to prevent, hinder, modify, delay or challenge the Mergers as contemplated by this Agreement.

Section 3.9 . The Company and each of its Subsidiaries are in compliance with all Laws applicable to them
or their businesses or activities, or by which any of their respective properties or assets are bound, except where any non-compliance would not, individually or the aggregate, reasonably be expected to have a
Material Adverse Effect. The Company and its Subsidiaries have in effect all permits, licenses, exemptions, authorizations, franchises, orders and approvals of all Governmental Entities (collectively, “”) necessary for them
to own, lease or operate their properties and to carry on their businesses and operations, inclusive of all pre-clinical and clinical studies, as now conducted, except for any Permits the absence of which
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

A-14

All Permits are in full force and effect, except where the failure to be in full force and effect would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.

Section 3.10 .

(a) of the Company Disclosure Letter sets forth a true and complete list of each Company Plan, other than any
employment, termination or severance letter or agreement for non-officer employees of the Company or its Subsidiaries and equity award